227 related articles for article (PubMed ID: 11953826)
1. Genetic abnormalities detected in ependymomas by comparative genomic hybridisation.
Carter M; Nicholson J; Ross F; Crolla J; Allibone R; Balaji V; Perry R; Walker D; Gilbertson R; Ellison DW
Br J Cancer; 2002 Mar; 86(6):929-39. PubMed ID: 11953826
[TBL] [Abstract][Full Text] [Related]
2. Comparative genomic hybridization detects specific cytogenetic abnormalities in pediatric ependymomas and choroid plexus papillomas.
Grill J; Avet-Loiseau H; Lellouch-Tubiana A; Sévenet N; Terrier-Lacombe MJ; Vénuat AM; Doz F; Sainte-Rose C; Kalifa C; Vassal G
Cancer Genet Cytogenet; 2002 Jul; 136(2):121-5. PubMed ID: 12237235
[TBL] [Abstract][Full Text] [Related]
3. Low frequency of chromosomal imbalances in anaplastic ependymomas as detected by comparative genomic hybridization.
Scheil S; Brüderlein S; Eicker M; Herms J; Herold-Mende C; Steiner HH; Barth TF; Möller P
Brain Pathol; 2001 Apr; 11(2):133-43. PubMed ID: 11303789
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups.
Hirose Y; Aldape K; Bollen A; James CD; Brat D; Lamborn K; Berger M; Feuerstein BG
Am J Pathol; 2001 Mar; 158(3):1137-43. PubMed ID: 11238062
[TBL] [Abstract][Full Text] [Related]
5. Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade.
Rousseau A; Idbaih A; Ducray F; Crinière E; Fèvre-Montange M; Jouvet A; Delattre JY
J Neurooncol; 2010 May; 97(3):353-64. PubMed ID: 19865800
[TBL] [Abstract][Full Text] [Related]
6. [Detection of chromosomal imbalance in ependymoma by comparative genomic hybridization].
Wu WX; Yu SZ; Sun CY; Wang Q; Jin SM; An TL
Zhonghua Bing Li Xue Za Zhi; 2009 Mar; 38(3):148-52. PubMed ID: 19575847
[TBL] [Abstract][Full Text] [Related]
7. Inverse correlation between genetic aberrations and malignancy grade in ependymal tumors: a paradox?
Gilhuis HJ; van der Laak J; Wesseling P; Boerman RH; Beute G; Teepen JL; Grotenhuis JA; Kappelle AC
J Neurooncol; 2004 Jan; 66(1-2):111-6. PubMed ID: 15015776
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas.
Lamszus K; Lachenmayer L; Heinemann U; Kluwe L; Finckh U; Höppner W; Stavrou D; Fillbrandt R; Westphal M
Int J Cancer; 2001 Mar; 91(6):803-8. PubMed ID: 11275983
[TBL] [Abstract][Full Text] [Related]
9. Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma.
Ward S; Harding B; Wilkins P; Harkness W; Hayward R; Darling JL; Thomas DG; Warr T
Genes Chromosomes Cancer; 2001 Sep; 32(1):59-66. PubMed ID: 11477662
[TBL] [Abstract][Full Text] [Related]
10. Genomic characterization of ependymomas reveals 6q loss as the most common aberration.
Olsen TK; Gorunova L; Meling TR; Micci F; Scheie D; Due-Tønnessen B; Heim S; Brandal P
Oncol Rep; 2014 Aug; 32(2):483-90. PubMed ID: 24939246
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas.
von Haken MS; White EC; Daneshvar-Shyesther L; Sih S; Choi E; Kalra R; Cogen PH
Genes Chromosomes Cancer; 1996 Sep; 17(1):37-44. PubMed ID: 8889505
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity on chromosome 22 in human ependymomas.
Huang B; Starostik P; Kühl J; Tonn JC; Roggendorf W
Acta Neuropathol; 2002 Apr; 103(4):415-20. PubMed ID: 11904762
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.
Ebert C; von Haken M; Meyer-Puttlitz B; Wiestler OD; Reifenberger G; Pietsch T; von Deimling A
Am J Pathol; 1999 Aug; 155(2):627-32. PubMed ID: 10433955
[TBL] [Abstract][Full Text] [Related]
14. Correlation between localization, age, and chromosomal imbalances in ependymal tumours as detected by CGH.
Jeuken JW; Sprenger SH; Gilhuis J; Teepen HL; Grotenhuis AJ; Wesseling P
J Pathol; 2002 Jun; 197(2):238-44. PubMed ID: 12015749
[TBL] [Abstract][Full Text] [Related]
15. 9p21 and 13q14 dosages in ependymomas. A clinicopathologic study of 101 cases.
Rajaram V; Leuthardt EC; Singh PK; Ojemann JG; Brat DJ; Prayson RA; Perry A
Mod Pathol; 2004 Jan; 17(1):9-14. PubMed ID: 14631364
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of histopathological ependymoma variants.
Neumann JE; Spohn M; Obrecht D; Mynarek M; Thomas C; Hasselblatt M; Dorostkar MM; Wefers AK; Frank S; Monoranu CM; Koch A; Witt H; Kool M; Pajtler KW; Rutkowski S; Glatzel M; Schüller U
Acta Neuropathol; 2020 Feb; 139(2):305-318. PubMed ID: 31679042
[TBL] [Abstract][Full Text] [Related]
17. Analysis of chromosome 7 in adult and pediatric ependymomas using chromogenic in situ hybridization.
Santi M; Quezado M; Ronchetti R; Rushing EJ
J Neurooncol; 2005 Mar; 72(1):25-8. PubMed ID: 15803371
[TBL] [Abstract][Full Text] [Related]
18. Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma.
Reardon DA; Entrekin RE; Sublett J; Ragsdale S; Li H; Boyett J; Kepner JL; Look AT
Genes Chromosomes Cancer; 1999 Mar; 24(3):230-7. PubMed ID: 10451703
[TBL] [Abstract][Full Text] [Related]
19. Karyotype studies in 18 ependymomas with literature review of 107 cases.
Mazewski C; Soukup S; Ballard E; Gotwals B; Lampkin B
Cancer Genet Cytogenet; 1999 Aug; 113(1):1-8. PubMed ID: 10459338
[TBL] [Abstract][Full Text] [Related]
20. Study of chromosome 9q gain, Notch pathway regulators and Tenascin-C in ependymomas.
Gupta RK; Sharma MC; Suri V; Kakkar A; Singh M; Sarkar C
J Neurooncol; 2014 Jan; 116(2):267-74. PubMed ID: 24178439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
